Письмо Министерства здравоохранения РФ от 5 марта 2019 г. N 15-4/И/2-1908


Критерии оценки качества медицинской помощи в программах ВРТ



страница159/159
Дата12.12.2019
Размер1.64 Mb.
ТипПротокол
1   ...   151   152   153   154   155   156   157   158   159

Критерии оценки качества медицинской помощи в программах ВРТ




Критерии оценки качества медицинской помощи, оказанной пациентам в программах ВРТ





N

Критерии качества

Оценка выполнения

1.

Проведение предусмотренного обследования пациентов к применению программ ВРТ

Да/Нет

2.

Обоснование выбора программ ВРТ

Да/Нет

3.

УЗ мониторинг состояния эндометрия и яичников

Да/Нет

4.

Своевременное проведение пункции фолликулов яичников

Да/Нет

5.

Использование хирургических методов получения сперматозоидов (при наличии показаний)

Да/Нет

6.

Проведение программы ИКСИ (при наличии показаний)

Да/Нет

7.

Проведение биопсии бластомеров и/или трофэктодермы (при наличии показаний)

Да/Нет

8.

Перенос в полость матки не более 2 эмбрионов

Да/Нет

9.

Проведение криоконсервации гамет и эмбрионов (при наличии показаний, соответствующих объектов и информированного согласия пациентов)

Да/Нет

10.

Профилактика развития тяжелых стадий синдрома гиперстимуляции яичников

Да/Нет

11.

Проведение программ "Донорство спермы", "Донорство ооцитов", "Суррогатное материнство", "Донорство эмбрионов" (при наличии показаний)

Да/Нет



Показатели хорошего качества работы лаборатории ВРТ





Показатель

Достаточный уровень

"Золотой" стандарт

Доля полученных ооцитов (ооциты/фолликулы)

-

80-95%

Доля зрелых ооцитов (ооциты MII/все ооциты)

-

75-90%

Доля прогрессивно подвижных сперматозоидов после обработки эякулята

90%

95%

Доля полиспермии после ЭКО (3PN/инсеминированные ОКК)

<6%

<6%

Доля 1PN после ЭКО (1PN/инсеминированные ОКК)

<5%

<5%

Доля 1PN после ИКСИ (1PN/инжектированные MII)

<3%

< 3%

Доля бластоцист хорошего качества на 5-й день (бластоцисты/2PN)





Доля оплодотворения после ЭКО (2PN/полученные ОКК)





Доля оплодотворения после ИКСИ (2PN/полученные ОКК)





Отсутствие оплодотворения в цикле (циклы с отсутствием оплодотворения/все циклы со стимуляцией)

<5%

<5%

Доля дегенерации после ИКСИ (дегенерированные MII/инжектированные MII)





Процент дробления на 2-й день (делящиеся эмбрионы/2PN)





Доля развития на 2-й день (эмбрионы с 4 бластомерами/2PN)





Доля развития на 3-й день (эмбрионы с 8 бластомерами/2PN)





Доля развития на 5-й день (бластоцисты/2PN)





Доля успешности биопсий (образцы с прошедшей амплификацией/все образцы)





Доля выживания оттаянных бластоцист (выжившие бластоцисты/все размороженные бластоцисты)





Доля имплантации дробящихся эмбрионов (число плодных яиц по данным УЗИ/число перенесенных эмбрионов)





Доля имплантации бластоцист (число плодных яиц по данным УЗИ/число перенесенных бластоцист)







Список литературы

1. Jungwirth A, Diemer T, Kopa Z. Male Infertility. EAU guidelines. 2016.

2. Чалый М.Е., Ахвледиани Н.Д., Харчилава Р.Р. Мужское бесплодие. Российские клинические рекомендации. Урология. 2016; (1):2-16.

3. World Health Organization. WHO laboratory manual for the examination and processing of human semen - 5th ed. 2010. 287 p.

4. Баранов В.С., Кузнецова Т.В. Цитогенетика эмбрионального развития человека: Научно-практические аспекты. Издательст. СПб; 2006. 640 p.

5. Гинтер ЕК ПВ. Наследственные болезни. Национальное руководство. Краткое издание. ГЭОТАР-Мед. Москва; 2017. 464 p.

6. Strandell A, Lindhard A, Eckerlund I. Cost-effectiveness analysis of salpingectomy prior to IVF, based on a randomized controlled trial. Hum Reprod [Internet]. 2005;20(12):3284-92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16096324

7. Noventa M, Gizzo S, Saccardi C, Borgato S, Vitagliano A, Quaranta M, et al. Salpingectomy before assisted reproductive technologies: a systematic literature review. J Ovarian Res [Internet]. 2016;9(1):74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27809927

8. Fauser BCJM, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril [Internet]. 2012;97(1):28-38.e25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22153789

9. Адамян Л.В., Андреева Е.Н., Аполихина И.А., Беженарь В.Ф., Геворкян М.А., Гус А.И., et al. Эндометриоз: диагностика, лечение и реабилитация. Клинические рекомендации МЗ РФ. Москва; 2013. 89 p.

10. Dunselman GAJ, Vermeulen N, Becker C, Calhaz-Jorge C, D'Hooghe T, De Bie B, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014 Mar;29(3):400-12.

11. Levine D, Brown DL, Andreotti RF, Benacerraf B, Benson CB, Brewster WR, et al. Management of asymptomatic ovarian and other adnexal cysts imaged at US: Society of Radiologists in Ultrasound Consensus Conference Statement. Radiology [Internet]. 2010;256(3):943-54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20505067

12. Einarsson S, Bergh C, Friberg B, Pinborg A, Klajnbard A, Karlstrom P-O, et al. Weight reduction intervention for obese infertile women prior to IVF: a randomized controlled trial. Hum Reprod. 2017;32(8):1621-30.

13. Mushtaq R, Pundir J, Achilli C, Naji O, Khalaf Y, El-Toukhy T. Effect of male body mass index on assisted reproduction treatment outcome: an updated systematic review and meta-analysis. Reprod Biomed Online [Internet]. 2018;36(4):459-71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29452915

14. O'Flynn N. Assessment and treatment for people with fertility problems: NICE guideline. Br J Gen Pract [Internet]. 2014;64(618):50-1. Available from: http://bjgp.org/lookup/doi/10.3399/bjgp14X676609

15. van Wely M, Kwan I, Burt AL, Thomas J, Vail A, Van der Veen F, et al. Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles. A Cochrane review. Hum Reprod Update [Internet]. 18(2):111. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22301671

16. Weigert M, Krischker U, M, Poschalko G, Kindermann C, Feichtinger W. Comparison of stimulation with clomiphene citrate in combination with recombinant follicle-stimulating hormone and recombinant luteinizing hormone to stimulation with a gonadotropin-releasing hormone agonist protocol: a prospective, randomized study. Fertil Steril [Internet]. 2002; 78(1):34-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12095487

17. Kuang Y, Chen Q, Hong Q, Lyu Q, Ai A, Fu Y, et al. Double stimulations during the follicular and luteal phases of poor responders in IVF/ICSI programmes (Shanghai protocol). Reprod Biomed Online [Internet]. 2014;29(6):684-91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25444501

18. Gupta S, Satwik R, Majumdar A, Mittal S, Tiwari N. Clomiphene based ovarian stimulation in a commercial donor program. J Hum Reprod Sci [Internet]. 8(3):142-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26538856

19. Gibreel A, Maheshwari A, Bhattacharya S. Clomiphene citrate in combination with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilization. Cochrane database Syst Rev. 2012;11:CD008528.

20. Mochtar MH, Danhof NA, Ayeleke RO, Van der Veen F, van Wely M. Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles. Cochrane database Syst Rev. 2017; 5:CD005070.

21. Alviggi C, Conforti A, Esteves SC, Andersen CY, Bosch E, Buhler K, et al. Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review. Fertil Steril [Internet]. 2018;109(4):644-64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29653717

22. Lensen SF, Wilkinson J, Leijdekkers JA, La Marca A, Mol BWJ, Marjoribanks J, et al. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI). Cochrane database Syst Rev. 2018;2:CD012693.

23. Вспомогательные репродуктивные технологии (ВРТ). Рекомендации для врачей. 2007. 60 p.

24. Al-Inany HG, Youssef MA, Ayeleke RO, Brown J, Lam WS, Broekmans FJ. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane database Syst Rev. 2016;4:CD001750.

25. Tang H, Mourad S, Zhai S-D, Hart RJ. Dopamine agonists for preventing ovarian hyperstimulation syndrome. Cochrane database Syst Rev. 2016;11:CD008605.

26. Lambalk CB, Banga FR, Huirne JA, Toftager M, Pinborg A, Homburg R, et al. GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type. Hum Reprod Update. 2017;23(5):560-79.

27. Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org, Practice Committee of the American Society for Reproductive Medicine. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil Steril [Internet]. 2016;106(7):1634-47. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27678032

28. Wang R, Lin S, Wang Y, Qian W, Zhou L. Comparisons of GnRH antagonist protocol versus GnRH agonist long protocol in patients with normal ovarian reserve: A systematic review and meta-analysis. PLoS One [Internet]. 2017;12(4):e0175985. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28437434

29. Youssef MAFM, Van der Veen F, Al-Inany HG, Mochtar MH, Griesinger G, Nagi Mohesen M, et al. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology. Cochrane database Syst Rev. 2014;(10):CD008046.

30. Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective rando. Fertil Steril [Internet]. 2008;89(1):84-91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17462639

31. Melo M, Busso CE, Bellver J, Alama P, Garrido N, Meseguer M, et al. GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study. Reprod Biomed Online [Internet]. 2009;19(4):486-92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19909588

32. Улезко-Строгонова К.П. Къ вопросу о тончайшемъ строении децидуальной ткани, ее гистогенезъ, значенiи и месте развития въ половомъ аппарате женщины. Ж Акушерства и женскихъ болезней. 1908;(7, 8).

33. Никитин А.И. Комментарий к статье В.С. Корсака "К вопросу о роли эндометрия в имплантации эмбрионов". Проблемы репродукции. 2016; 22(3):127-8.

34. Kasius A, Smit JG, Torrance HL, Eijkemans MJC, Mol BW, Opmeer BC, et al. Endometrial thickness and pregnancy rates after IVF: a systematic review and meta-analysis. Hum Reprod Update [Internet]. 20(4):530-41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24664156

35. Check JH, Cohen R. Live fetus following embryo transfer in a woman with diminished egg reserve whose maximal endometrial thickness was less than 4 mm. Clin Exp Obstet Gynecol [Internet]. 2011;38(4):330-2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22268267

36. Jimenez PT, Schon SB, Odem RR, Ratts VS, Jungheim ES. A retrospective cross-sectional study: fresh cycle endometrial thickness is a sensitive predictor of inadequate endometrial thickness in frozen embryo transfer cycles. Reprod Biol Endocrinol [Internet]. 2013; 11:35. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23663223

37. Simon A, Laufer N. Assessment and treatment of repeated implantation failure (RIF). J Assist Reprod Genet [Internet]. 2012;29(11):1227-39. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22976427

38. Chen S-L, Wu F-R, Luo C, Chen X, Shi X-Y, Zheng H-Y, et al. Combined analysis of endometrial thickness and pattern in predicting outcome of in vitro fertilization and embryo transfer: a retrospective cohort study. Reprod Biol Endocrinol [Internet]. 2010;8:30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20334664

39. Wiser A, Gonen O, Ghetler Y, Shavit T, Berkovitz A, Shulman A. Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study. Hum Reprod [Internet]. 2010;25(10):2496-500. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20729538

40. Duffy JM, Ahmad G, Mohiyiddeen L, Nardo LG, Watson A. Growth hormone for in vitro fertilization. Cochrane database Syst Rev [Internet]. 2010;(1):CD000099. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20091500

41. Farquhar C, Rombauts L, Kremer JA, Lethaby A, Ayeleke RO. Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques. Cochrane database Syst Rev. 2017;5:CD006109.

42. Chang FE, Beall SA, Cox JM, Richter KS, DeCherney AH, Levy MJ. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response. Fertil Steril [Internet]. 2016;106(5):1093-1100.e3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27341988

43. Garcia-Velasco JA, Fatemi HM. To pill or not to pill in GnRH antagonist cycles: that is the question! Reprod Biomed Online [Internet]. 2015;30(1):39-42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25447926

44. Reichman DE, Chung P, Meyer L, Greenwood E, Davis O, Rosenwaks Z. Consecutive gonadotropin-releasing hormone-antagonist in vitro fertilization cycles: does the elapsed time interval between successive treatments affect outcomes? Fertil Steril [Internet]. 2013 Apr; 99(5):1277-82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23290740

45. Caligara C, Navarro J, Vargas G, Simon C, Pellicer A, J. The effect of repeated controlled ovarian stimulation in donors. Hum Reprod [Internet]. 2001 Nov;16(11):2320-3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11679512



46. Higgins C, Healey M, Jatkar S, Vollenhoven B. Interval between IVF stimulation cycle and frozen embryo transfer: Is there a benefit to a delay between cycles? Aust N Z J Obstet Gynaecol [Internet]. 2018 Apr;58(2):217-21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28905357

47. Wikland M, Blad S, Bungum L, T, PO, Nilsson S. A randomized controlled study comparing pain experience between a newly designed needle with a thin tip and a standard needle for oocyte aspiration. Hum Reprod [Internet]. 2011;26(6):1377-83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21467200

48. Weiss A, Neril R, Geslevich J, Lavee M, Beck-Fruchter R, Golan J, et al. Lag time from ovulation trigger to oocyte aspiration and oocyte maturity in assisted reproductive technology cycles: a retrospective study. Fertil Steril [Internet]. 2014;102(2):419-23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24880653

49. Nargund G, Reid F, Parsons J. Human chorionic gonadotropin-to-oocyte collection interval in a superovulation IVF program. A prospective study. J Assist Reprod Genet [Internet]. 2001;18(2):87-90. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11285986

50. Bjercke S, Tanbo T, Dale PO, Abyholm T. Comparison between two hCG-to-oocyte aspiration intervals on the outcome of in vitro fertilization. J Assist Reprod Genet [Internet]. 2000;17(6):319-22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11042828

51. Mansour RT, Aboulghar MA, Serour GI. Study of the optimum time for human chorionic gonadotropin-ovum pickup interval in in vitro fertilization. J Assist Reprod Genet [Internet]. 1994;11(9):478-81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7633170

52. Wang W, Zhang X-H, Wang W-H, Liu Y-L, Zhao L-H, Xue S-L, et al. The time interval between hCG priming and oocyte retrieval in ART program: a meta-analysis. J Assist Reprod Genet [Internet]. 2011;28(10):901-10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21792666

53. Levy G, Hill MJ, Ramirez CI, Correa L, Ryan ME, DeCherney AH, et al. The use of follicle flushing during oocyte retrieval in assisted reproductive technologies: a systematic review and meta-analysis. Hum Reprod [Internet]. 2012;27(8):2373-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22647450

54. Farquhar C, Rishworth JR, Brown J, Nelen WLDM, Marjoribanks J. Assisted reproductive technology: an overview of Cochrane Reviews. Cochrane database Syst Rev [Internet]. 2015;(7):CD010537. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26174592

55. Glujovsky D, Farquhar C, Quinteiro Retamar AM, Alvarez Sedo CR, Blake D. Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology. Cochrane database SystRev. 2016;(6):CD002118.

56. Phillips SJ, Dean NL, Buckett WM, Tan SL. Consecutive transfer of day 3 embryos and of day 5-6 blastocysts increases overall pregnancy rates associated with blastocyst culture. J Assist Reprod Genet [Internet]. 2003;20(11):461-4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14714825

57. Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org, Practice Committee of the American Society for Reproductive Medicine. Performing the embryo transfer: a guideline. Fertil Steril [Internet]. 2017;107(4):882-96. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28366416

58. Brown J, Buckingham K, Buckett W, Abou-Setta AM. Ultrasound versus "clinical touch" for catheter guidance during embryo transfer in women. Cochrane database Syst Rev. 2016;3:CD006107.

59. Buckett WM. A review and meta-analysis of prospective trials comparing different catheters used for embryo transfer. Fertil Steril [Internet]. 2006;85(3):728-34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16500345

60. Sroga JM, Montville CP, Aubuchon M, Williams DB, Thomas MA. Effect of delayed versus immediate embryo transfer catheter removal on pregnancy outcomes during fresh cycles. Fertil Steril [Internet]. 2010;93(6):2088-90. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20116786

61. Tiras B, Polat M, Korucuoglu U, Zeyneloglu HB, Yarali H. Impact of embryo replacement depth on in vitro fertilization and embryo transfer outcomes. Fertil Steril [Internet]. 2010;94(4):1341-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20044085

62. Bontekoe S, Heineman MJ, Johnson N, Blake D. Adherence compounds in embryo transfer media for assisted reproductive technologies. Cochrane database Syst Rev. 2014;(2):CD007421.

63. Craciunas L, Tsampras N, Fitzgerald C. Cervical mucus removal before embryo transfer in women undergoing in vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril [Internet]. 2014;101(5):1302-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24602754

64. Oraif A, Hollet-Caines J, Feyles V, Rebel M, Abduljabar H. Do multiple attempts at embryo transfer affect clinical pregnancy rates? J Obstet Gynaecol Can. 2014;36(5):406-7.

65. Kroon B, Hart RJ, Wong BMS, Ford E, Yazdani A. Antibiotics prior to embryo transfer in ART. Cochrane database Syst Rev [Internet]. 2012;(3):CD008995. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22419341

66. van der Ven H, Diedrich K, Al-Hasani S, Pless V, Krebs D. The effect of general anaesthesia on the success of embryo transfer following human in-vitro fertilization. Hum Reprod [Internet]. 1988;3 Suppl 2:81-3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3068244

67. European IVF-monitoring Consortium (EIM), European Society of Human Reproduction and Embryology (ESHRE), Calhaz-Jorge C, De Geyter C, Kupka MS, de Mouzon J, et al. Assisted reproductive technology in Europe, 2013: results generated from European registers by ESHRE. Hum Reprod. 2017; 32(10):1957-73.

68. Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org, Practice Committee of the Society for Assisted Reproductive Technology. Guidance on the limits to the number of embryos to transfer: a committee opinion. Fertil Steril [Internet]. 2017;107(4):901-3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28292618

69. Mancuso AC, Boulet SL, Duran E, Munch E, Kissin DM, Van Voorhis BJ. Elective single embryo transfer in women less than age 38 years reduces multiple birth rates, but not live birth rates, in United States fertility clinics. Fertil Steril. 2016 Oct;106(5):1107-14.

70. Kissin DM, Kulkarni AD, Mneimneh A, Warner L, Boulet SL, Crawford S, et al. Embryo transfer practices and multiple births resulting from assisted reproductive technology: an opportunity for prevention. Fertil Steril [Internet]. 2015;103(4):954-61. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25637480

71. Richter KS, Ginsburg DK, Shipley SK, Lim J, Tucker MJ, Graham JR, et al. Factors associated with birth outcomes from cryopreserved blastocysts: experience from 4,597 autologous transfers of 7,597 cryopreserved blastocysts. Fertil Steril [Internet]. 2016;106(2):354-362.e2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27172399

72. Chen X, Liu P, Sheng Y, Li W, Tang R, Ding L, et al. The impact of unicornuate uterus on perinatal outcomes after IVF/ICSI cycles: a matched retrospective cohort study. J Matern Fetal Neonatal Med [Internet]. 2018;1-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29649918

73. JOINT SOGC-CFAS. Guidelines for the number of embryos to transfer following in vitro fertilization No. 182, September 2006. Int J Gynaecol Obstet. 2008;102(2):203-16.

74. Prevention of twin pregnancies after IVF/ICSI by single embryo transfer. ESHRE Campus Course Report. Hum Reprod [Internet]. 2001;16(4):790-800. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11278236

75. Soliman S, Daya S, Collins J, Hughes EG. The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials. Fertil Steril [Internet]. 1994;61(6):1068-76. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8194619

76. Connell MT, Szatkowski JM, Terry N, DeCherney AH, Propst AM, Hill MJ. Timing luteal support in assisted reproductive technology: a systematic review. Fertil Steril [Internet]. 2015;103(4):939-946.e3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25638420

77. van der Linden M, Buckingham K, Farquhar C, Kremer JAM, Metwally M. Luteal phase support for assisted reproduction cycles. Cochrane database Syst Rev. 2015;(7):CD009154.

78. Child T, Leonard SA, Evans JS, Lass A. Systematic review of the clinical efficacy of vaginal progesterone for luteal phase support in assisted reproductive technology cycles. Reprod Biomed Online [Internet]. 2018;36(6):630-45. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29550390

79. Shapiro DB, Pappadakis JA, Ellsworth NM, Hait HI, Nagy ZP. Progesterone replacement with vaginal gel versus i.m. injection: cycle and pregnancy outcomes in IVF patients receiving vitrified blastocysts. Hum Reprod [Internet]. 2014;29(8):1706-11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24847018

80. Tournaye H, Sukhikh GT, Kahler E, Griesinger G. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization. Hum Reprod [Internet]. 2017;32(10):2152. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28938733

81. Применение эстрогенов в программах ВРТ. Научно-практические рекомендации. РАРЧ. 2015.

82. Корсак В.С., Каменецкий Б.А., Михайлов А.В. Значимость толщины и ультразвуковой структуры эндометрия в программе ЭКО. Проблемы репродукции. 2001;7(3):36-9.

83. Aydin T, Kara M, Nurettin T. Relationship between Endometrial Thickness and In Vitro Fertilization-Intracytoplasmic Sperm Injection Outcome. Int J Fertil Steril [Internet]. 2013;7(1):29-34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24520460

84. Al-Ghamdi A, Coskun S, Al-Hassan S, Al-Rejjal R, Awartani K. The correlation between endometrial thickness and outcome of in vitro fertilization and embryo transfer (IVF-ET) outcome. Reprod Biol Endocrinol [Internet]. 2008;6:37. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18764940

85. Xiao Z, Zhou X, Xu W, Yang J, Xie Q. Natural cycle is superior to hormone replacement therapy cycle for vitrificated-preserved frozen-thawed embryo transfer. Syst Biol Reprod Med [Internet]. 2012;58(2):107-12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22206474

86. Groenewoud ER, Macklon NS, Cohlen BJ, trial study group A. Cryo-thawed embryo transfer: natural versus artificial cycle. A non-inferiority trial. (ANTARCTICA trial). BMC Womens Health [Internet]. 2012;12:27. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22950651

87. Liao X, Li Z, Dong X, Zhang H. Comparison between oral and vaginal estrogen usage in inadequate endometrial patients for frozen-thawed blastocysts transfer. Int J Clin Exp Pathol [Internet]. 2014;7(10):6992-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25400786

88. Mao G-H, Feng Z, He Y, Huang Y-R. Comparisons of the effects of long-acting and shortacting GnRH agonists on embryo quality, endometrial thickness and pregnancy rate in human in vitro fertilization. Arch Med Sci [Internet]. 2014;10(1):161-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24701229

89. Jung H, Roh HK. The effects of E2 supplementation from the early proliferative phase to the late secretory phase of the endometrium in hMG-stimulated IVF-ET. J Assist Reprod Genet [Internet]. 2000;17(1):28-33. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10754780

90. Kol S. Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome. Fertil Steril [Internet]. 2004;81(1):1-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14711532

91. Корсак В.С., Смирнова А.А., Шурыгина О.В. Регистр центров ВРТ в России. Отчет за 2015 г. Проблемы репродукции. 2017;23(5):8-22.

92. Корнеева Е.И. Федеральные клинические рекомендации. Диагностика и лечение синдрома гиперстимуляции яичников. Москва; 2013.

93. Casper RF. Reducing the Risk of OHSS by GnRH Agonist Triggering. J Clin Endocrinol Metab [Internet]. 2015;100(12):4396-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26513003

94. Leitao VMS, Moroni RM, Seko LMD, Nastri CO, Martins WP. Cabergoline for the prevention of ovarian hyperstimulation syndrome: systematic review and meta-analysis of randomized controlled trials. Fertil Steril [Internet]. 2014;101(3):664-75. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24360566

95. Sousa M, Cunha M, Teixeira da Silva J, Oliveira C, Silva J, Viana P, et al. Ovarian hyperstimulation syndrome: a clinical report on 4894 consecutive ART treatment cycles. Reprod Biol Endocrinol [Internet]. 2015;13:66. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26100393

96. Das M, Son W-Y, Buckett W, Tulandi T, Holzer H. In-vitro maturation versus IVF with GnRH antagonist for women with polycystic ovary syndrome: treatment outcome and rates of ovarian hyperstimulation syndrome. Reprod Biomed Online [Internet]. 2014;29(5):545-51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25262236

97. Refaat B, Dalton E, Ledger WL. Ectopic pregnancy secondary to in vitro fertilisation-embryo transfer: pathogenic mechanisms and management strategies. Reprod Biol Endocrinol [Internet]. 2015;13:30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25884617

98. Shaw JL V, Dey SK, Critchley HOD, Horne AW. Current knowledge of the aetiology of human tubal ectopic pregnancy. Hum Reprod Update [Internet]. 16(4):432-44. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20071358

99. Ankum WM, Mol BW, Van der Veen F, Bossuyt PM. Risk factors for ectopic pregnancy: a meta-analysis. Fertil Steril [Internet]. 1996;65(6):1093-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8641479

100. Audebert A, Pouly JL, Bonifacie B, Yazbeck C. Laparoscopic surgery for distal tubal occlusions: lessons learned from a historical series of 434 cases. Fertil Steril [Internet]. 2014;102(4):1203-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25150389

101. Hjordt Hansen M V, Dalsgaard T, Hartwell D, Skovlund CW, Lidegaard O. Reproductive prognosis in endometriosis. A national cohort study. Acta Obstet Gynecol Scand [Internet]. 2014;93(5):483-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24617701

102. Egbase PE, Al-Sharhan M, Grudzinskas JG. Influence of position and length of uterus on implantation and clinical pregnancy rates in IVF and embryo transfer treatment cycles. Hum Reprod [Internet]. 2000;15(9):1943-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10966991

103. Nazari A, Askari HA, Check JH, O'Shaughnessy A. Embryo transfer technique as a cause of ectopic pregnancy in in vitro fertilization. Fertil Steril [Internet]. 1993;60(5):919-21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8224280

104. Pandian Z, Marjoribanks J, Ozturk O, Serour G, Bhattacharya S. Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection. Cochrane database Syst Rev. 2013;(7):CD003416.

105. Vloeberghs V, Peeraer K, Pexsters A, D'Hooghe T. Ovarian hyperstimulation syndrome and complications of ART. Best Pract Res Clin Obstet Gynaecol [Internet]. 2009;23(5):691-709. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19632900

106. S, Kumbasar S, Savan K. Evaluation of complications developing during and after transvaginal ultrasound - guided oocyte retrieval. Ginekol Pol [Internet]. 2018;89(1):1-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29411339

107. Bodri D, JJ, Polo A, Trullenque M, Esteve C, Coll O. Complications related to ovarian stimulation and oocyte retrieval in 4052 oocyte donor cycles. Reprod Biomed Online [Internet]. 2008;17(2):237-43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18681998

108. Ludwig AK, Glawatz M, Griesinger G, Diedrich K, Ludwig M. Perioperative and postoperative complications of transvaginal ultrasound-guided oocyte retrieval: prospective study of >1000 oocyte retrievals. Hum Reprod [Internet]. 2006;21(12):3235-40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16877373

109. Sarhan A, Muasher SJ. Surgical complications of in vitro fertilization. Review. Middle East Fert Soc J.2007;12(1):N1.

110. Serour GI, Aboulghar M, Mansour R, Sattar MA, Amin Y, Aboulghar H. Complications of medically assisted conception in 3,500 cycles. Fertil Steril [Internet]. 1998;70(4):638-42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9797090

111. Roest J, Mous H V, Zeilmaker GH, Verhoeff A. The incidence of major clinical complications in a Dutch transport IVF programme. Hum Reprod Update [Internet]. 2(4):345-53. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9080231

112. Govaerts I, Devreker F, Delbaere A, Revelard P, Englert Y. Short-term medical complications of 1500 oocyte retrievals for in vitro fertilization and embryo transfer. Eur J Obstet Gynecol Reprod Biol [Internet]. 1998;77(2):239-43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9578285

113. Кулаков В.И., Леонов Б.В. Экстракорпоральное оплодотворение и его новые направления в лечении женского и мужского бесплодия (теоретические и практические подходы): Руководство для врачей. МИА. Москва; 2004. 782 p.

114. Mashiach S, Bider D, Moran O, Goldenberg M, Ben-Rafael Z. Adnexal torsion of hyperstimulated ovaries in pregnancies after gonadotropin therapy. Fertil Steril [Internet]. 1990; 53(1):76-80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2295348

115. Romanski PA, Melamed A, Elias KM, Stanic AK, Anchan RM. Association between peak estradiol levels and ovarian torsion among symptomatic patients receiving gonadotropin treatment. J Assist Reprod Genet [Internet]. 2017;34(5):627-31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28299550

116. Kemmann E, Ghazi DM, Corsan GH. Adnexal torsion in menotropin-induced pregnancies. Obstet Gynecol [Internet]. 1990;76(3 Pt 1):403-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2116611

117. Bouguizane S, Bibi H, Farhat Y, Dhifallah S, Darraji F, Hidar S, et al. [Adnexal torsion: a report of 135 cases]. J Gynecol Obstet Biol Reprod (Paris) [Internet]. 2003;32(6):535-40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14593299

118. Chang HC, Bhatt S, Dogra VS. Pearls and pitfalls in diagnosis of ovarian torsion. Radiographics [Internet]. 28(5):1355-68. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18794312

119. Huchon C, Fauconnier A. Adnexal torsion: a literature review. Eur J Obstet Gynecol Reprod Biol [Internet]. 2010;150(1):8-12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20189289

120. Mashiach R, Melamed N, Gilad N, Ben-Shitrit G, Meizner I. Sonographic diagnosis of ovarian torsion: accuracy and predictive factors. J Ultrasound Med [Internet]. 2011;30(9):1205-10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21876091

121. Steyaert SR, Leroux-Roels GG, Dhont M. Infections in IVF: review and guidelines. Hum Reprod Update [Internet]. 6(5):432-41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11045874

122. Assisted reproductive technology in Europe 2013: results generated from European registers by ESHRE., Calhaz-Jorge C, Christian De Geyter, M S Kupka et al. Revised guidelines for good practice in IVF laboratories (2015). Hum Reprod [Internet]. 2017;32(10):1957-73. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26908842

123. Pereira N, Hutchinson AP, Lekovich JP, Hobeika E, Elias RT. Antibiotic Prophylaxis for Gynecologic Procedures prior to and during the Utilization of Assisted Reproductive Technologies: A Systematic Review. J Pathog [Internet]. 2016;2016:4698314. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27047692

124. Arafa M, El Tabie O. Medical treatment of retrograde ejaculation in diabetic patients: a hope for spontaneous pregnancy. J Sex Med [Internet]. 2008;5(1):194-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17433085

125. Ohl DA, Quallich SA, Sonksen J, Brackett NL, Lynne CM. Anejaculation and retrograde ejaculation. Urol Clin North Am [Internet]. 2008;35(2):211-20, viii. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18423241

126. Brackett NL, Ibrahim E, Iremashvili V, Aballa TC, Lynne CM. Treatment for ejaculatory dysfunction in men with spinal cord injury: an 18-year single center experience. J Urol [Internet]. 2010; 183(6):2304-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20400139

127. Ohl DA, Quallich SA, Sonksen J, Brackett NL, Lynne CM. Anejaculation: an electrifying approach. Semin Reprod Med [Internet]. 2009;27(2):179-85. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19247920

128. Brackett NL, Lynne CM, Ibrahim E, Ohl DA, Sonksen J. Treatment of infertility in men with spinal cord injury. Nat Rev Urol [Internet]. 2010;7(3):162-72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20157304

129. Корнеев И.А., Зассеев Р.Д. Преодоление бесплодия у мужчин с ретроградной эякуляцией и анэякуляцией. Урологические ведомости. 2017;7(2):10-5.

130. Colpi GM, Piediferro G, Nerva F, Giacchetta D, Colpi EM, Piatti E. Sperm retrieval for intra-cytoplasmic sperm injection in non-obstructive azoospermia. Minerva Urol Nefrol [Internet]. 2005;57(2):99-107. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15951734

131. Deruyver Y, Vanderschueren D, Van der Aa F. Outcome of microdissection TESE compared with conventional TESE in non-obstructive azoospermia: a systematic review. Andrology [Internet]. 2014;2(1):20-4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24193894

132. Krausz C, Degl'Innocenti S. Y chromosome and male infertility: update, 2006. Front Biosci [Internet]. 2006;11:3049-61. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16720375

133. Ghanem M, Bakr NI, Elgayaar MA, El Mongy S, Fathy H, Ibrahim A-HA. Comparison of the outcome of intracytoplasmic sperm injection in obstructive and non-obstructive azoospermia in the first cycle: a report of case series and meta-analysis. Int J Androl [Internet]. 2005;28(1):16-21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15679616

134. Vernaeve V, Tournaye H, Osmanagaoglu K, Verheyen G, Van Steirteghem A, Devroey P. Intracytoplasmic sperm injection with testicular spermatozoa is less successful in men with nonobstructive azoospermia than in men with obstructive azoospermia. Fertil Steril [Internet]. 2003;79(3):529-33. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12620435

135. Vloeberghs V, Verheyen G, Haentjens P, Goossens A, Polyzos NP, Tournaye H. How successful is TESE-ICSI in couples with non-obstructive azoospermia? Hum Reprod [Internet]. 2015;30(8):1790-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26082482

136. Aksglaede L, Juul A. Testicular function and fertility in men with Klinefelter syndrome: a review. Eur J Endocrinol [Internet]. 2013;168(4):R67-76. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23504510

137. Gies I, De Schepper J, Goossens E, Van Saen D, Pennings G, Tournaye H. Spermatogonial stem cell preservation in boys with Klinefelter syndrome: to bank or not to bank, that's the question. Fertil Steril [Internet]. 2012;98(2):284-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22608314

138. Kastrop PM, Weima SM, Van Kooij RJ, Te Velde ER. Comparison between intracytoplasmic sperm injection and in-vitro fertilization (IVF) with high insemination concentration after total fertilization failure in a previous IVF attempt. Hum Reprod [Internet]. 1999; 14(1):65-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10374096

139. Verheyen G, Tournaye H, Staessen C, De Vos A, Vandervorst M, Van Steirteghem A. Controlled comparison of conventional in-vitro fertilization and intracytoplasmic sperm injection in patients with asthenozoospermia. Hum Reprod [Internet]. 1999;14(9):2313-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10469701

140. Payne D, Flaherty SP, Jeffrey R, Warnes GM, Matthews CD. Successful treatment of severe male factor infertility in 100 consecutive cycles using intracytoplasmic sperm injection. Hum Reprod [Internet]. 1994;9(11):2051-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7868673

141. Plachot M, Belaisch-Allart J, Mayenga J-M, Chouraqui A, Tesquier L, Serkine AM. Outcome of conventional IVF and ICSI on sibling oocytes in mild male factor infertility. Hum Reprod [Internet]. 2002;17(2):362-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11821279

142. Henkel RR, Schill W-B. Sperm preparation for ART. Reprod Biol Endocrinol [Internet]. 2003;1:108. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14617368

143. Beydola T, Sharma RK, Agarwal A. Sperm preparation and selection techniques. Med Surg Manag male Infertil. 2014;(29):244-51.

144. on Good EGG. Revised guidelines for good practice in IVF laboratories (2015): Guideline of the European Society of Human Reproduction and Embryology.

145. Huang Z, Li J, Wang L, Yan J, Shi Y, Li S. Brief co-incubation of sperm and oocytes for in vitro fertilization techniques. Cochrane database Syst Rev. 2013;(4):CD009391.

146. Kazem R, Thompson LA, Srikantharajah A, Laing MA, Hamilton MP, Templeton A. Cryopreservation of human oocytes and fertilization by two techniques: in-vitro fertilization and intracytoplasmic sperm injection. Hum Reprod [Internet]. 1995;10(10):2650-4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8567786

147. Gook DA, Edgar DH. Human oocyte cryopreservation. Hum Reprod Update [Internet]. 13(6):591-605. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17846105

148. Harton GL, Magli MC, Lundin K, Montag M, Lemmen J, Harper JC, et al. ESHRE PGD Consortium/Embryology Special Interest Group-best practice guidelines for polar body and embryo biopsy for preimplantation genetic diagnosis/screening (PGD/PGS). Hum Reprod [Internet]. 2011;26(1):41-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20966459

149. Thornhill AR, DeDie-Smulders CE, Geraedts JP, Harper JC, Harton GL, Lavery SA, et al. ESHRE PGD Consortium "Best practice guidelines for clinical preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS)". Hum Reprod [Internet]. 2005;20(1):35-48. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15539444

150. ESHRE Capri Workshop Group. Intracytoplasmic sperm injection (ICSI) in 2006: evidence and evolution. Hum Reprod Update [Internet]. 13(6):515-26. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17630396

151. Practice Committees of the American Society for Reproductive Medicine and Society for Assisted Reproductive Technology. Intracytoplasmic sperm injection (ICSI) for non-male factor infertility: a committee opinion. Fertil Steril [Internet]. 2012;98(6):1395-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22981171

152. van der Westerlaken L, Helmerhorst F, Dieben S, Naaktgeboren N. Intracytoplasmic sperm injection as a treatment for unexplained total fertilization failure or low fertilization after conventional in vitro fertilization. Fertil Steril [Internet]. 2005;83(3):612-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15749489

153. Kinzer DR, Barrett CB, Powers RD. Prognosis for clinical pregnancy and delivery after total fertilization failure during conventional in vitro fertilization or intracytoplasmic sperm injection. Fertil Steril [Internet]. 2008;90(2):284-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17714711

154. Johnson LNC, Sasson IE, Sammel MD, Dokras A. Does intracytoplasmic sperm injection improve the fertilization rate and decrease the total fertilization failure rate in couples with well-defined unexplained infertility? A systematic review and meta-analysis. Fertil Steril [Internet]. 2013;100(3):704-11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23773312

155. Moreno C, Ruiz A, Simon C, Pellicer A, Remohi J. Intracytoplasmic sperm injection as a routine indication in low responder patients. Hum Reprod [Internet]. 1998;13(8):2126-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9756282

156. Luna M, Bigelow C, Duke M, Ruman J, Sandler B, Grunfeld L, et al. Should ICSI be recommended routinely in patients with four or fewer oocytes retrieved? J Assist Reprod Genet [Internet]. 2011;28(10):911-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21792665

157. Kim HH, Bundorf MK, Behr B, McCallum SW. Use and outcomes of intracytoplasmic sperm injection for non-male factor infertility. Fertil Steril [Internet]. 2007;88(3):622-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17445809

158. Hwang JL, Lin YH, Tsai YL. In vitro maturation and fertilization of immature oocytes: a comparative study of fertilization techniques. J Assist Reprod Genet [Internet]. 2000;17(1):39-43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10754782

159. Nagy ZP, Cecile J, Liu J, Loccufier A, Devroey P, Van Steirteghem A. Pregnancy and birth after intracytoplasmic sperm injection of in vitro matured germinal-vesicle stage oocytes: case report. Fertil Steril [Internet]. 1996;65(5):1047-50. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8612833

160. Tucker M, Graham J, Han T, Stillman R, Levy M. Conventional insemination versus intracytoplasmic sperm injection. Lancet (London, England) [Internet]. 2001;358(9293):1645-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11716920

161. Teixeira DM, Barbosa MAP, Ferriani RA, Navarro PA, Raine-Fenning N, Nastri CO, et al. Regular (ICSI) versus ultra-high magnification (IMSI) sperm selection for assisted reproduction. Cochrane database Syst Rev. 2013;(7):CD010167.

162. McDowell S, Kroon B, Ford E, Hook Y, Glujovsky D, Yazdani A. Advanced sperm selection techniques for assisted reproduction. Cochrane database Syst Rev. 2014;(10):CD010461.

163. Cohen J, Alikani M, Trowbridge J, Rosenwaks Z. Implantation enhancement by selective assisted hatching using zona drilling of human embryos with poor prognosis. Hum Reprod [Internet]. 1992;7(5):685-91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1639990

164. Zeng M, Su S, Li L. The effect of laser-assisted hatching on pregnancy outcomes of cryopreserved-thawed embryo transfer: a meta-analysis of randomized controlled trials. Lasers Med Sci [Internet]. 2018;33(3):655-66. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29116610

165. Carney S-K, Das S, Blake D, Farquhar C, Seif MMW, Nelson L. Assisted hatching on assisted conception (in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI). Cochrane database Syst Rev. 2012;12:CD001894.

166. Capalbo A, Romanelli V, Cimadomo D, Girardi L, Stoppa M, Dovere L, et al. Implementing PGD/PGD-A in IVF clinics: considerations for the best laboratory approach and management. J Assist Reprod Genet [Internet]. 2016;33(10):1279-86. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27423665

167. Martins WP, Rocha IA, Ferriani RA, Nastri CO. Assisted hatching of human embryos: a systematic review and meta-analysis of randomized controlled trials. Hum Reprod Update [Internet]. 17(4):438-53. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21474527

168. Li D, Yang D-L, An J, Jiao J, Zhou Y-M, Wu Q-J, et al. Effect of assisted hatching on pregnancy outcomes: a systematic review and meta-analysis of randomized controlled trials. Sci Rep [Internet]. 2016;6:31228. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27503701

169. Goossens V, De Rycke M, De Vos A, Staessen C, Michiels A, Verpoest W, et al. Diagnostic efficiency, embryonic development and clinical outcome after the biopsy of one or two blastomeres for preimplantation genetic diagnosis. Hum Reprod [Internet]. 2008;23(3):481-92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18156649

170. De Vos A, Staessen C, De Rycke M, Verpoest W, Haentjens P, Devroey P, et al. Impact of cleavage-stage embryo biopsy in view of PGD on human blastocyst implantation: a prospective cohort of single embryo transfers. Hum Reprod [Internet]. 2009;24(12):2988-96. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19773223



171. Dumoulin JC, Bras M, Coonen E, Dreesen J, Geraedts JP, Evers JL. Effect of Ca2+/Mg2+free medium on the biopsy procedure for preimplantation genetic diagnosis and further development of human embryos. Hum Reprod [Internet]. 1998;13(1O):2880-3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9804249

172. Kahraman S, M, Samli H, N, Yakisn K, Cengiz G, et al. Healthy births and ongoing pregnancies obtained by preimplantation genetic diagnosis in patients with advanced maternal age and recurrent implantation failure. Hum Reprod [Internet]. 2000;15(9):2003-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10967004

173. S, Cohen J. Unsuitability of multinucleated human blastomeres for preimplantation genetic diagnosis. Hum Reprod [Internet]. 1993;8(7):1120-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8408497

174. Geber S, Bossi R, Lisboa CB, Valle M, Sampaio M. Laser confers less embryo exposure than acid tyrode for embryo biopsy in preimplantation genetic diagnosis cycles: a randomized study. Reprod Biol Endocrinol [Internet]. 2011;9:58. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21527004

175. Gardner DK, Schoolcraft WB. Culture and transfer of human blastocysts. Curr Opin Obs Gynecol. 1999;13(3):307-11.

176. Wininger JD, Taylor TH, Orris JJ, Glassner M, Anderson SH. Pregnancy after rebiopsy and vitrification of blastocysts following allele dropout after day 3 biopsy. Fertil Steril [Internet]. 2011;95(3):1122.e1-2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20951376

177. Greco E, Biricik A, Cotarelo RP, Iammarone E, Rubino P, Tesarik J, et al. Successful implantation and live birth of a healthy boy after triple biopsy and double vitrification of oocyte-embryo-blastocyst. Springerplus [Internet]. 2015;4:22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25625041

178. Eldar-Geva T, Srebnik N, Altarescu G, Varshaver I, Brooks B, Levy-Lahad E, et al. Neonatal outcome after preimplantation genetic diagnosis. Fertil Steril [Internet]. 2014;102(4):1016-21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25064409

179. De Vos A, Van Steirteghem A. Aspects of biopsy procedures prior to preimplantation genetic diagnosis. Prenat Diagn [Internet]. 2001;21(9):767-80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11559914

180. Rienzi L, Gracia C, Maggiulli R, LaBarbera AR, Kaser DJ, Ubaldi FM, et al. Oocyte, embryo and blastocyst cryopreservation in ART: systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance. Hum Reprod Update. 2017;23(2):139-55.

181. Cobo A, Meseguer M, J, Pellicer A. Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomized, controlled, clinical trial. Hum Reprod. 2010;25(9):2239-46.

182. Cobo A, Garrido N, Pellicer A, Remohi J. Six years' experience in ovum donation using vitrified oocytes: report of cumulative outcomes, impact of storage time, and development of a predictive model for oocyte survival rate. Fertil Steril [Internet]. 2015;104(6):1426-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26353081

183. Maheshwari A, Pandey S, Amalraj Raja E, Shetty A, Hamilton M, Bhattacharya S. Is frozen embryo transfer better for mothers and babies? Can cumulative meta-analysis provide a definitive answer? Hum Reprod Update. 2018;24(1):35-58.

184. Shi Q, Xie Y, Wang Y, Li S. Vitrification versus slow freezing for human ovarian tissue cryopreservation: a systematic review and meta-anlaysis. Sci Rep [Internet]. 2017;7(1):8538. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28819292

185. Zhou X-H, Zhang D, Shi J, Wu Y-J. Comparison of vitrification and conventional slow freezing for cryopreservation of ovarian tissue with respect to the number of intact primordial follicles: A meta-analysis. Medicine (Baltimore) [Internet]. 2016;95(39):e4095. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27684791

186. Justice T, Christensen G. Sperm cryopreservation methods. Methods Mol Biol [Internet]. 2013;927:209-15. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22992915

187. Levron J, Madgar I, Shefi S, Meirow D, Wiser A, Bider D, et al. IVF outcome with cryopreserved testicular sperm. Andrologia [Internet]. 2011;43(1):48-51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21219382

188. Hovatta O, Foudila T, Siegberg R, Johansson K, von Smitten K, Reima I. Pregnancy resulting from intracytoplasmic injection of spermatozoa from a frozen-thawed testicular biopsy specimen. Hum Reprod [Internet]. 1996;11(11):2472-3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8981136

189. Vajta G, Rienzi L, Ubaldi FM. Open versus closed systems for vitrification of human oocytes and embryos. Reprod Biomed Online [Internet]. 2015;30(4):325-33. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25639657

190. Youm HS, Choi J-R, Oh D, Rho YH. Survival Rates in Closed and Open Vitrification for Human Mature Oocyte Cryopreservation: A Meta-Analysis. Gynecol Obstet Invest [Internet]. 2018;83(3):268-74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29131105

191. Zegers-Hochschild F, Adamson GD, Dyer S, Racowsky C, de Mouzon J, Sokol R, et al. The International Glossary on Infertility and Fertility Care, 2017. Fertil Steril. 2017;108(3):393-406.

192. Гинтер ЕК, Пузырев ВП. Наследственные болезни. Национальное руководство. Краткое издание. ГЭОТАР-Мед. Москва; 2017. 464 p.

193. Daughtry BL, Chavez SL. Chromosomal instability in mammalian pre-implantation embryos: potential causes, detection methods, and clinical consequences. Cell Tissue Res [Internet]. 2016;363(1):201-25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26590822

194. Minasi MG, Colasante A, Riccio T, Ruberti A, Casciani V, Scarselli F, et al. Correlation between aneuploidy, standard morphology evaluation and morphokinetic development in 1730 biopsied blastocysts: a consecutive case series study. Hum Reprod. 2016;31(10):224554.

195. De Rycke M, Goossens V, Kokkali G, Meijer-Hoogeveen M, Coonen E, Moutou C. ESHRE PGD Consortium data collection XIV-XV: cycles from January 2011 to December 2012 with pregnancy follow-up to October 2013. Hum Reprod [Internet]. 2017;32(10):1974-94. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29117384



196. PGDIS position statement on chromosome mosaicism and preimplantation aneuploidy testing at the blastocyst stage. Chicago: PGDIS Newsletter, July 19, 2016.

197. Liss J, Chromik I, J, M, A, K. Current methods for preimplantation genetic diagnosis. Ginekol Pol [Internet]. 2016;87(7):522-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27504946

198. Kane SC, Willats E, Bezerra Maia E Holanda Moura S, Hyett J, da Silva Costa F. PreImplantation Genetic Screening Techniques: Implications for Clinical Prenatal Diagnosis. Fetal Diagn Ther [Internet]. 2016;40(4):241-54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27682145

199. Chen H-F, Chen S-U, Ma G-C, Hsieh S-T, Tsai H-D, Yang Y-S, et al. Preimplantation genetic diagnosis and screening: Current status and future challenges. J Formos Med Assoc [Internet]. 2018;117(2):94-100. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28888353

200. Lu L, Lv B, Huang K, Xue Z, Zhu X, Fan G. Recent advances in preimplantation genetic diagnosis and screening. J Assist Reprod Genet [Internet]. 2016;33(9):1129-34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27272212

201. Brezina PR, Anchan R, Kearns WG. Preimplantation genetic testing for aneuploidy: what technology should you use and what are the differences? J Assist Reprod Genet. 2016 Jul;33(7):823-32.

202. Рыжкова О, Кардымон О, Прохорчук Е. Руководство по интерпретации данных, полученных методами массового параллельного секвенирования (MPS). Медицинская генетика. 2017;16(7):4-17.

203. Deglincerti A, Croft GF, Pietila LN, Zernicka-Goetz M, Siggia ED, Brivanlou AH. Selforganization of the in vitro attached human embryo. Nature [Internet]. 2016;533(7602):251-4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27144363

204. Practice Committee of American Society for Reproductive Medicine, Practice Committee of Society for Assisted Reproductive Technology. Recommendations for gamete and embryo donation: a committee opinion. Fertil Steril [Internet]. 2013;99(1):47-62. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23095142

205. Ethics Committee of the American Society for Reproductive Medicine. Oocyte or embryo donation to women of advanced age: a committee opinion. Fertil Steril [Internet]. 2013;100(2):337-40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23472948

206. Ethics Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org, Ethics Committee of the American Society for Reproductive Medicine. Oocyte or embryo donation to women of advanced reproductive age: an Ethics Committee opinion. Fertil Steril [Internet]. 2016;106(5):e3-e7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27450186

207. Le Ray C, Scherier S, Anselem O, Marszalek A, Tsatsaris V, Cabrol D, et al. Association between oocyte donation and maternal and perinatal outcomes in women aged 43 years or older. Hum Reprod [Internet]. 2012;27(3):896-901. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22252087

208. Practice Committee of the American Society for Reproductive Medicine and Practice Committee of the Society for Assisted Reproductive Technology. Electronic address: ASRM@asrm.org, Practice Committee of the American Society for Reproductive Medicine and Practice Committee of the Society for Assisted Reproductive Technology. Recommendations for practices utilizing gestational carriers: a committee opinion. Fertil Steril [Internet]. 2017;107(2):e3-e10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28069181

209. Сельков С.А., Ярмолинская М.И. Эндометриоз как патология регуляторных механизмов. Журнал акушерства и женских болезней. 2017;66(2):9-13.

210. Schifrin BS, Erez S, Moore JG. Teen-age endometriosis. Am J Obstet Gynecol [Internet]. 1973;116(7):973-80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/4718224

211. Wheeler JM. Epidemiology of endometriosis-associated infertility. J Reprod Med [Internet]. 1989;34(1):41-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2704007

212. Giudice LC, Kao LC. Endometriosis. Lancet (London, England) [Internet]. 364(9447):1789-99. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15541453

213. Fuentes A, Escalona J, P, Espinoza A, Johnson MC. [Prevalence of endometriosis in 287 women undergoing surgical sterilization in Santiago Chile]. Rev Med Chil [Internet]. 2014;142(1):16-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24861109

214. Macer ML, Taylor HS. Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility. Obstet Gynecol Clin North Am [Internet]. 2012;39(4):535-49. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23182559

215. Bondza PK, Maheux R, Akoum A. Insights into endometriosis-associated endometrial dysfunctions: a review. Front Biosci (Elite Ed) [Internet]. 2009;1:415-28. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19482656

216. Saito H, Seino T, Kaneko T, Nakahara K, Toya M, Kurachi H. Endometriosis and oocyte quality. Gynecol Obstet Invest [Internet]. 2002;53 Suppl 1:46-51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11834868

217. Mansour G, Aziz N, Sharma R, Falcone T, Goldberg J, Agarwal A. The impact of peritoneal fluid from healthy women and from women with endometriosis on sperm DNA and its relationship to the sperm deformity index. Fertil Steril [Internet]. 2009;92(1):61-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19409553

218. Mansour G, Sharma RK, Agarwal A, Falcone T. Endometriosis-induced alterations in mouse metaphase II oocyte microtubules and chromosomal alignment: a possible cause of infertility. Fertil Steril [Internet]. 2010;94(5):1894-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19896655

219. Garrido N, Navarro J, Garcia-Velasco J, Remoh J, Pellice A, Simon C. The endometrium versus embryonic quality in endometriosis-related infertility. Hum Reprod Update [Internet]. 8(1):95-103. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11866246

220. Kissler S, Zangos S, Wiegratz I, Kohl J, Rody A, Gaetje R, et al. Utero-tubal sperm transport and its impairment in endometriosis and adenomyosis. Ann N Y Acad Sci [Internet]. 2007;1101:38-48. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17344532

221. Barnhart K, Dunsmoor-Su R, Coutifaris C. Effect of endometriosis on in vitro fertilization. Fertil Steril [Internet]. 2002;77(6):1148-55. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12057720

222. Oral E, Olive DL, Arici A. The peritoneal environment in endometriosis. Hum Reprod Update [Internet]. 2(5):385-98. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15717438



223. S, R, Lousse J-C, Colette S, Donnez O, Donnez J, et al. Insights into iron and nuclear factor-kappa B (NF-kappaB) involvement in chronic inflammatory processes in peritoneal endometriosis. Histol Histopathol [Internet]. 2011;26(8):1083-92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21692040

224. Lousse J-C, Van Langendonckt A, Defrere S, Ramos RG, Colette S, Donnez J. Peritoneal endometriosis is an inflammatory disease. Front Biosci (Elite Ed) [Internet]. 2012;4:23-40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22201853

225. Duffy JMN, Arambage K, Correa FJS, Olive D, Farquhar C, Garry R, et al. Laparoscopic surgery for endometriosis. Cochrane database Syst Rev. 2014;(4):CD011031.

226. Ponce C, Torres M, Galleguillos C, Sovino H, Boric MA, Fuentes A, et al. Nuclear factor kappaB pathway and interleukin-6 are affected in eutopic endometrium of women with endometriosis. Reproduction [Internet]. 2009;137(4):727-37. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19129371

227. Yap C, Furness S, Farquhar C. Pre and post operative medical therapy for endometriosis surgery. Cochrane database Syst Rev. 2004;(3):CD003678.

228. Adamson GD, Pasta DJ. Endometriosis fertility index: the new, validated endometriosis staging system. Fertil Steril. 2010 Oct;94(5):1609-15.

229. Zikopoulos K, Kolibianakis EM, Devroey P. Ovarian stimulation for in vitro fertilization in patients with endometriosis. Acta Obstet Gynecol Scand [Internet]. 2004;83(7):651-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15225190

230. Rickes D, Nickel I, Kropf S, Kleinstein J. Increased pregnancy rates after ultralong postoperative therapy with gonadotropin-releasing hormone analogs in patients with endometriosis. Fertil Steril [Internet]. 2002;78(4):757-62. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12372452

231. Sallam HN, Garcia-Velasco JA, Dias S, Arici A. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane database Syst Rev [Internet]. 2006;(1):CD004635. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16437491

232. Gong F, Tang Y, Zhang H, Lu G. Modified super-long down-regulation protocol improved the outcome of in vitro fertilization-embryo transfer in infertile patients. Zhong Nan Da Xue Xue Bao Yi Xue Ban [Internet]. 2009;34(3):185-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19349670

233. van der Houwen LEE, Mijatovic V, Leemhuis E, Schats R, Heymans MW, Lambalk CB, et al. Efficacy and safety of IVF/ICSI in patients with severe endometriosis after long-term pituitary down-regulation. Reprod Biomed Online [Internet]. 2014;28(1):39-46. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24262434

234. Giudice LC, Evers LH, Healy DL, editors. Endometriosis: science and practice. London: Wiley-Blackwell; 2012. 600 p.

235. Смольникова ВЮС. Изучение особенностей действия агонистов гонадотропинрилизинг гормона - депо-декапептила и нафарелина в программе экстракорпорального оплодотворения и переноса эмбрионов в полость матки. Москва; 1995. 24 p.

236. Surrey ES, Silverberg KM, Surrey MW, Schoolcraft WB. Effect of prolonged gonadotropinreleasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis. Fertil Steril [Internet]. 2002;78(4):699-704. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12372443

237. Kennedy S, Bergqvist A, Chapron C, D'Hooghe T, Dunselman G, Greb R, et al. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod [Internet]. 2005;20(10):2698-704. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15980014

238. Leung AS, Dahan MH. The benefits of other treatments than in vitro fertilization to aid conception in minimal and mild endometriosis. Minerva Ginecol [Internet]. 2016;68(6):675-86. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27077394

239. Boujenah J, Santulli P, Mathieu-d'Argent E, Decanter C, Chauffour C, Poncelet P. [First line management without IVF of infertility related to endometriosis: Result of medical therapy? Results of ovarian superovulation? Results of intrauterine insemination? CNGOF-HAS Endometriosis Guidelines]. Gynecol Obstet Fertil Senol [Internet]. 2018;46(3):331-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29551300

240. Geisler ME, Ledwidge M, Bermingham M, McAuliffe M, McMenamin MB, Waterstone JJ. Intrauterine insemination-No more Mr. N.I.C.E. guy? Eur J Obstet Gynecol Reprod Biol [Internet]. 2017;210:342-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28122315

241. Siristatidis CS, Gibreel A, Basios G, Maheshwari A, Bhattacharya S. Gonadotrophinreleasing hormone agonist protocols for pituitary suppression in assisted reproduction. Cochrane database Syst Rev. 2015;(11):CD006919.

242. Bastu E, Yasa C, Dural O, Mutlu MF, Celik C, Ugurlucan FG, et al. Comparison of ovulation induction protocols after endometrioma resection. JSLS J Soc Laparoendosc Surg [Internet]. 18(3). Available from: http://www.ncbi.nlm.nih.gov/pubmed/25392665

243. Pabuccu R, Onalan G, Kaya C. GnRH agonist and antagonist protocols for stage I-II endometriosis and endometrioma in in vitro fertilization/intracytoplasmic sperm injection cycles. Fertil Steril [Internet]. 2007;88(4):832-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17428479

244. Kitajima M, Khan KN, Harada A, Taniguchi K, Inoue T, Kaneuchi M, et al. Association between ovarian endometrioma and ovarian reserve. Front Biosci (Elite Ed) [Internet]. 2018;10:92-102. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28930606

245. Yanushpolsky EH, Best CL, Jackson K V, Clarke RN, Barbieri RL, Hornstein MD. Effects of endometriomas on ooccyte quality, embryo quality, and pregnancy rates in in vitro fertilization cycles: a prospective, case-controlled study. J Assist Reprod Genet [Internet]. 1998;15(4):193-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9565848

246. Matsuzaki S, Schubert B. Oxidative stress status in normal ovarian cortex surrounding ovarian endometriosis. Fertil Steril. 2010 May;93(7):2431-2.

247. Brosens I. Endometriosis and the outcome of in vitro fertilization. Fertil Steril [Internet]. 2004;81(5):1198-200. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15136075

248. Geber S, Ferreira DP, Spyer Prates LFV, Sales L, Sampaio M. Effects of previous ovarian surgery for endometriosis on the outcome of assisted reproduction treatment. Reprod Biomed Online [Internet]. 5(2):162-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12419041

249. Muzii L, Di Tucci C, Di Feliciantonio M, Marchetti C, Perniola G, Panici PB. The effect of surgery for endometrioma on ovarian reserve evaluated by antral follicle count: a systematic review and meta-analysis. Hum Reprod. 2014 Oct;29(10):2190-8.

250. Raffi F, Metwally M, Amer S. The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab [Internet]. 2012;97(9):3146-54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22723324

251. Garcia-Velasco JA, Mahutte NG, Corona J, Zuniga V, Giles J, Arici A, et al. Removal of endometriomas before in vitro fertilization does not improve fertility outcomes: a matched, case-control study. Fertil Steril [Internet]. 2004;81(5):1194-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15136074

252. Somigliana E, Arnoldi M, Benaglia L, Iemmello R, Nicolosi AE, Ragni G. IVF-ICSI outcome in women operated on for bilateral endometriomas. Hum Reprod [Internet]. 2008;23(7):1526-30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18441346

253. Ruiz Anguas J, Carballo Mondragon E, Anta Jaen E, Monterrosas L, Kably Ambe A. [Clinical implication and frequency of the incidental finding of endometriosis during oocyte retrieval]. Ginecol Obstet Mex [Internet]. 2007;75(3):121-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17547085

254. Cirpan T, Akercan F, Tavmergen Goker EN, Ozyurek E, Levi R, Tavmergen E. Laparoscopic resection or sonography-guided vaginal aspiration of endometriomas prior to ICSI-ET does not worsen treatment outcomes. Clin Exp Obstet Gynecol [Internet]. 2007;34(4):215-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18225681

255. Demirol A, Guven S, Baykal C, Gurgan T. Effect of endometrioma cystectomy on IVF outcome: a prospective randomized study. Reprod Biomed Online [Internet]. 2006;12(5):639-43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16790114

256. Yu H-T, Huang H-Y, Tseng H-J, Wang C-J, Lee C-L, Soong Y-K. Bilaterality of ovarian endometriomas does not affect the outcome of in vitro fertilization/intracytoplasmic sperm injection in infertile women after laparoscopic cystectomy. Biomed J [Internet]. 2017;40(5):295-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29179885

257. Hamdan M, Dunselman G, Li TC, Cheong Y. The impact of endometrioma on IVF/ICSI outcomes: a systematic review and meta-analysis. Hum Reprod Update [Internet]. 21(6):809-25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26168799

258. Leone Roberti Maggiore U, Gupta JK, Ferrero S. Treatment of endometrioma for improving fertility. Eur J Obstet Gynecol Reprod Biol [Internet]. 2017;209:81-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26968428

259. Jadoul P, Kitajima M, Donnez O, Squifflet J, Donnez J. Surgical treatment of ovarian endometriomas: state of the art? Fertil Steril [Internet]. 2012;98(3):556-63. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22763094

260. Younes G, Tulandi T. Effects of adenomyosis on in vitro fertilization treatment outcomes: a meta-analysis. Fertil Steril [Internet]. 2017;108(3):483-490.e3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28865548

261. Mavrelos D, Holland TK, O'Donovan O, Khalil M, Ploumpidis G, Jurkovic D, et al. The impact of adenomyosis on the outcome of IVF-embryo transfer. Reprod Biomed Online [Internet]. 2017;35(5):549-54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28802706

262. Dueholm M. Uterine adenomyosis and infertility, review of reproductive outcome after in vitro fertilization and surgery. Acta Obstet Gynecol Scand [Internet]. 2017;96(6):715-26. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28556124

263. Vercellini P, Consonni D, Dridi D, Bracco B, Frattaruolo MP, Somigliana E. Uterine adenomyosis and in vitro fertilization outcome: a systematic review and meta-analysis. Hum Reprod. 2014;29(5):964-77.

264. Soave I, Wenger J-M, Pluchino N, Marci R. Treatment options and reproductive outcome for adenomyosis-associated infertility. Curr Med Res Opin [Internet]. 2018;34(5):839-49. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29046066

265. Назаренко Т.А. Стимуляция функции яичников. М.: МЕДпресс-информ; 2015. 288 p.

266. Wang B, Kong N, Liu J-Y, Zhang N-Y, Zhu Y-C, Zhou J-J. [Repeated superovulation induction after failure in previous IVF-ET cycles with the ultra-long protocol: Analysis of outcomes of clinical pregnancy]. Zhonghua Nan Ke Xue [Internet]. 2017;23(12):1099-102. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29738181

267. Jeve YB, Bhandari HM. Effective treatment protocol for poor ovarian response: A systematic review and meta-analysis. J Hum Reprod Sci [Internet]. 9(2):70-81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27382230

268. Youssef MA-F, van Wely M, Mochtar M, Fouda UM, Eldaly A, El Abidin EZ, et al. Low dosing of gonadotropins in in vitro fertilization cycles for women with poor ovarian reserve: systematic review and meta-analysis. Fertil Steril [Internet]. 2018;109(2):289-301. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29317127

269. Baker VL, Brown MB, Luke B, Smith GW, Ireland JJ. Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles. Fertil Steril [Internet]. 2015;104(5):1145. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26297646

270. Fan W, Li S, Chen Q, Huang Z, Ma Q, Wang Y. Recombinant Luteinizing Hormone supplementation in poor responders undergoing IVF: a systematic review and meta-analysis. Gynecol Endocrinol [Internet]. 2013;29(4):278-84. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23347045

271. Lehert P, Kolibianakis EM, Venetis CA, Schertz J, Saunders H, Arriagada P, et al. Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis. Reprod Biol Endocrinol [Internet]. 2014;12:17. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24555766

272. Youssef MA, van Wely M, Al-Inany H, Madani T, Jahangiri N, Khodabakhshi S, et al. A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial. Hum Reprod. 2017;32(1):112-8.

273. Ragni G, Levi-Setti PE, Fadini R, Brigante C, Scarduelli C, Alagna F, et al. Clomiphene citrate versus high doses of gonadotropins for in vitro fertilisation in women with compromised ovarian reserve: a randomised controlled non-inferiority trial. Reprod Biol Endocrinol [Internet]. 2012;10:114. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23249758

274. Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org. Comparison of pregnancy rates for poor responders using IVF with mild ovarian stimulation versus conventional IVF: a guideline. Fertil Steril [Internet]. 2018;109(6):993-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29935660

275. Polyzos NP, Blockeel C, Verpoest W, De Vos M, Stoop D, Vloeberghs V, et al. Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria. Hum Reprod. 2012;27(12):3481-6.

276. Reynolds KA, Omurtag KR, Jimenez PT, Rhee JS, Tuuli MG, Jungheim ES. Cycle cancellation and pregnancy after luteal estradiol priming in women defined as poor responders: a systematic review and meta-analysis. Hum Reprod [Internet]. 2013;28(11):2981-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23887073

277. Vaiarelli A, Cimadomo D, Trabucco E, Vallefuoco R, Buffo L, Dusi L, et al. Double Stimulation in the Same Ovarian Cycle (DuoStim) to Maximize the Number of Oocytes Retrieved From Poor Prognosis Patients: A Multicenter Experience and SWOT Analysis. Front Endocrinol (Lausanne) [Internet]. 2018;9:317. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29963011

278. Humaidan P, Alviggi C, Fischer R, Esteves SC. The novel POSEIDON stratification of "Low prognosis patients in Assisted Reproductive Technology" and its proposed marker of successful outcome. F1000Research [Internet]. 2016;5:2911. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28232864

279. Poseidon Group (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number), Alviggi C, Andersen CY, Buehler K, Conforti A, De Placido G, et al. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil Steril [Internet]. 2016;105(6):1452-3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26921622

280. Cobo A, Garrido N, Crespo J, Jose R, Pellicer A. Accumulation of oocytes: a new strategy for managing low-responder patients. Reprod Biomed Online [Internet]. 2012;24(4):424-32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22386762



281. Forman EJ, Hong KH, Ferry KM, Tao X, Taylor D, Levy B, et al. In vitro fertilization with single euploid blastocyst transfer: a randomized controlled trial. Fertil Steril. 2013 Jul;100(1):100-7.e1.

282. Galliano D, Bellver J, C, C, Pellicer A. ART and uterine pathology: how relevant is the maternal side for implantation? Hum Reprod Update [Internet]. 21(1):13-38. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25155826

283. Kremer C, Duffy S, Moroney M. Patient satisfaction with outpatient hysteroscopy versus day case hysteroscopy: randomised controlled trial. BMJ [Internet]. 2000;320(7230):279-82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10650023

284. Guida M, Pellicano M, Zullo F, Acunzo G, Lavitola G, Palomba S, et al. Outpatient operative hysteroscopy with bipolar electrode: a prospective multicentre randomized study between local anaesthesia and conscious sedation. Hum Reprod [Internet]. 2003;18(4):840-3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12660281

285. Pellicano M, Guida M, Zullo F, Lavitola G, Cirillo D, Nappi C. Carbon dioxide versus normal saline as a uterine distension medium for diagnostic vaginoscopic hysteroscopy in infertile patients: a prospective, randomized, multicenter study. Fertil Steril [Internet]. 2003;79(2):418-21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12568856

286. AAGL Practice Report: Practice Guidelines for the Diagnosis and Management of Submucous Leiomyomas. J Minim Invasive Gynecol [Internet]. 2012;19(2):152-71. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1553465011011897

287. Marret H, Fritel X, Ouldamer L, Bendifallah S, Brun J-L, De Jesus I, et al. Therapeutic management of uterine fibroid tumors: updated French guidelines. Eur J Obstet Gynecol Reprod Biol [Internet]. 2012;165(2):156-64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22939241

288. Klatsky PC, Tran ND, Caughey AB, Fujimoto VY. Fibroids and reproductive outcomes: a systematic literature review from conception to delivery. Am J Obstet Gynecol [Internet]. 2008;198(4):357-66. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18395031

289. Коган И.Ю., Беженарь В.Ф., Долинский А.К., Чмаро М.Г. Эффективность вспомогательных методов репродукции у больных с миомой матки. Журнал акушерства и женских болезней. 2012;(4):113-8.

290. Seki H, Takizawa Y, Sodemoto T. Epidural analgesia for painful myomas refractory to medical therapy during pregnancy. Int J Gynaecol Obstet [Internet]. 2003;83(3):303-4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14643043

291. Wiesenfeld HC, Hillier SL, Meyn LA, Amortegui AJ, Sweet RL. Subclinical pelvic inflammatory disease and infertility. Obstet Gynecol [Internet]. 2012;120(1):37-43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22678036

292. Тапильскя Н.И., Карпеев С.А., Гайдуков С.Н. Обоснование эффективности антибактериальной терапии в лечении хронической воспалительной болезни матки. Вестник дерматологии и венерологии. 2015;(2):130-8.

293. Шуршалина, А.В. Клинико-морфологические особенности хронического эндометрита у женщин с нарушением репродуктивной функции: дис. ...д-ра мед. наук: 14.01.01/Шуршалина Анна Владимировна. - М., 2007. - 280 с.

294. Шуршалина А.В. Роль хронического эндометрита в развитии патологии репродуктивной функции. Российский медицинский журнал. 2007;(4):25-7.

295. Cicinelli E, Matteo M, Tinelli R, Lepera A, Alfonso R, Indraccolo U, et al. Prevalence of chronic endometritis in repeated unexplained implantation failure and the IVF success rate after antibiotic therapy. Hum Reprod [Internet]. 2015;30(2):323-30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25385744

296. Romero R, Espinoza J, Mazor M. Can endometrial infection/inflammation explain implantation failure, spontaneous abortion, and preterm birth after in vitro fertilization? Fertil Steril [Internet]. 2004;82(4):799-804. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15482749

297. Сухих Г, Шуршалина А. Хронический эндометрит. ГЭОТАР-Мед. Москва; 2010.

298. Khastgir G, Abdalla H, Thomas A, Korea L, Latarche L, Studd J. Oocyte donation in Turner's syndrome: an analysis of the factors affecting the outcome. Hum Reprod [Internet]. 1997;12(2):279-85. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9070711

299. Abir R, Fisch B, Nahum R, Orvieto R, Nitke S, Ben Rafael Z. Turner's syndrome and fertility: current status and possible putative prospects. Hum Reprod Update [Internet]. 7(6):603-10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11727869

300. Hovatta O. Ovarian function and in vitro fertilization (IVF) in Turner syndrome. Pediatr Endocrinol Rev [Internet]. 2012;9 Suppl 2:713-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22946282

301. SWYER GI. Male pseudohermaphroditism: a hitherto undescribed form. Br Med J [Internet]. 1955;2(4941):709-12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/13250193

302. Hagman A, Loft A, Wennerholm U-B, Pinborg A, Bergh C, K, et al. Obstetric and neonatal outcome after oocyte donation in 106 women with Turner syndrome: a Nordic cohort study. Hum Reprod [Internet]. 2013;28(6):1598-609. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23539610

303. Practice Committee of American Society For Reproductive Medicine. Increased maternal cardiovascular mortality associated with pregnancy in women with Turner syndrome. Fertil Steril [Internet]. 2012;97(2):282-4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22192347



304. Creatsas G, Deligeoroglou E, Tsimaris P, Pantos K, Kreatsa M. Successful pregnancy in a Swyer syndrome patient with preexisting hypertension. Fertil Steril [Internet]. 2011;96(2):e83-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21782051

305. Morcel K, Camborieux L, Programme de Recherches sur les Aplasies , Guerrier D. (MRKH) syndrome. Orphanet J Rare Dis [Internet]. 2007;2:13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17359527

306. MORRIS JM. The syndrome of testicular feminization in male pseudohermaphrodites. Am J Obstet Gynecol [Internet]. 1953;65(6):1192-211. Available from: http://www.ncbi.nlm.nih.gov/pubmed/13057950

307. Committee on Adolescent Health Care. ACOG Committee Opinion No. 728: Agenesis: Diagnosis, Management, And Treatment. Obstet Gynecol [Internet]. 2018;131(1):e35-e42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29266078

308. Raziel A, Friedler S, Gidoni Y, Ben Ami I, Strassburger D, Ron-El R. Surrogate in vitro fertilization outcome in typical and atypical forms of Mayer-Rokitansky-Kuster-Hauser syndrome. Hum Reprod [Internet]. 2012;27(1):126-30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22052385



309. Wood EG, Batzer FR, Corson SL. Ovarian response to gonadotrophins, optimal method for oocyte retrieval and pregnancy outcome in patients with vaginal agenesis. Hum Reprod [Internet]. 1999;14(5):1178-81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10325257

310. Reichman DE, Laufer MR. syndrome: fertility counseling and treatment. Fertil Steril [Internet]. 2010;94(5):1941-3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20172513

311. Reichman D, Laufer MR, Robinson BK. Pregnancy outcomes in unicornuate uteri: a review. Fertil Steril [Internet]. 2009;91(5):1886-94. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18439594

312. Chan YY, Jayaprakasan K, Tan A, Thornton JG, Coomarasamy A, Raine-Fenning NJ. Reproductive outcomes in women with congenital uterine anomalies: a systematic review. Ultrasound Obstet Gynecol [Internet]. 2011;38(4):371-82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21830244

313. Grimbizis GF, Camus M, Tarlatzis BC, Bontis JN, Devroey P. Clinical implications of uterine malformations and hysteroscopic treatment results. Hum Reprod Update [Internet]. 7(2):161-74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11284660

314. Letterie GS. Management of congenital uterine abnormalities. Reprod Biomed Online [Internet]. 2011;23(1):40-52. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21652266

315. Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org, Practice Committee of the American Society for Reproductive Medicine. Uterine septum: a guideline. Fertil Steril [Internet]. 2016;106(3):530-40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27235766

316. Venetis CA, Papadopoulos SP, Campo R, Gordts S, Tarlatzis BC, Grimbizis GF. Clinical implications of congenital uterine anomalies: a meta-analysis of comparative studies. Reprod Biomed Online [Internet]. 2014;29(6):665-83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25444500

317. Dicker D, Ashkenazi J, Dekel A, Orvieto R, Feldberg D, Yeshaya A, et al. The value of hysteroscopic evaluation in patients with preclinical in-vitro fertilization abortions. Hum Reprod [Internet]. 1996;11(4):730-1. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8671317

318. Lavergne N, Aristizabal J, Zarka V, Erny R, Hedon B. Uterine anomalies and in vitro fertilization: what are the results? Eur J Obstet Gynecol Reprod Biol [Internet]. 1996;68(1-2):29-34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8886677

319. Brucker S, Rall K, Campo R, Oppelt P, Isaacson K. Treatment of Congenital Malformations. Semin Reprod Med. 2011 Mar;29(02):101-12.

320. Revel A. Defective endometrial receptivity. Fertil Steril [Internet]. 2012;97(5):1028-32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22542142

321. Pasquier C, Daudin M, Righi L, Berges L, Thauvin L, Berrebi A, et al. Sperm washing and virus nucleic acid detection to reduce HIV and hepatitis C virus transmission in serodiscordant couples wishing to have children. AIDS [Internet]. 2000;14(14):2093-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11061649

322. Semprini AE, Macaluso M, Hollander L, Vucetich A, Duerr A, Mor G, et al. Safe conception for HIV-discordant couples: insemination with processed semen from the HIV-infected partner. Am J Obstet Gynecol [Internet]. 2013;208(5):402.e1-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23395921

323. Steenvoorden MMC, Cornelissen M, van Leeuwen E, Schuurman NM, Egberink HF, Berkhout B, et al. Integration of immunodeficiency virus in oocytes via intracytoplasmic injection: possible but extremely unlikely. Fertil Steril [Internet]. 2012;98(1):173-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22584022

324. Morgia F, Sbracia M, Schimberni M, Giallonardo A, Piscitelli C, Giannini P, et al. A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization. Fertil Steril [Internet]. 2004;81(6):1542-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15193474

325. Janssens RM, Lambalk CB, Schats R, Schoemaker J. Successful in-vitro fertilization in a natural cycle after four previously failed attempts in stimulated cycles: case report. Hum Reprod [Internet]. 1999;14(10):2497-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10527976

326. Pelinck MJ, Hoek A, Simons AHM, Heineman MJ. Efficacy of natural cycle IVF: a review of the literature. Hum Reprod Update [Internet]. 8(2):129-39. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12099628

327. Nargund G, Waterstone J, Bland J, Philips Z, Parsons J, Campbell S. Cumulative conception and live birth rates in natural (unstimulated) IVF cycles. Hum Reprod [Internet]. 2001;16(2):259-62. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11157816

328. Lenton EA. Natural cycle IVF with and without terminal HCG: learning from failed cycles. Reprod Biomed Online [Internet]. 2007;15(2):149-55. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17697489

329. Kadoch I-J, Phillips SJ, Bissonnette F. Modified natural-cycle in vitro fertilization should be considered as the first approach in young poor responders. Fertil Steril [Internet]. 2011;96(5):1066-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22036050

330. Ho JR, Paulson RJ. Modified natural cycle in in vitro fertilization. Fertil Steril [Internet]. 2017;108(4):572-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28965551

331. Shaulov T, MP, Buzaglo K, Phillips SJ, Kadoch IJ. Outcomes of 1503 cycles of modified natural cycle in vitro fertilization: a single-institution experience. J Assist Reprod Genet [Internet]. 2015;32(7):1043-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26041679



332. C, Olivennes F, Righini C, Fanchin R, J, Hamamah S, et al. Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophinreleasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation. Hum Reprod [Internet]. 1999;14(3):683-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10221695

333. Allersma T, Farquhar C, Cantineau AEP. Natural cycle in vitro fertilisation (IVF) for subfertile couples. Cochrane database Syst Rev. 2013;(8):CD010550.

334. Kamath MS, Kirubakaran R, Mascarenhas M, Sunkara SK. Perinatal outcomes after stimulated versus natural cycle IVF: a systematic review and meta-analysis. Reprod Biomed Online [Internet]. 2018;36(1):94-101. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29111312

335. Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. In vitro maturation: a committee opinion. Fertil Steril [Internet]. 2013;99(3):663-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23391409

336. Shalom-Paz E, Almog B, Shehata F, Huang J, Holzer H, Chian R-C, et al. Fertility preservation for breast-cancer patients using IVM followed by oocyte or embryo vitrification. Reprod Biomed Online [Internet]. 2010;21(4):566-71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20822957

337. Chang EM, Song HS, Lee DR, Lee WS, Yoon TK. In vitro maturation of human oocytes: Its role in infertility treatment and new possibilities. Clin Exp Reprod Med [Internet]. 2014;41(2):41-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25045627

338. Hourvitz A, Maman E, Brengauz M, Machtinger R, Dor J. In vitro maturation for patients with repeated in vitro fertilization failure due to "oocyte maturation abnormalities". Fertil Steril [Internet]. 2010;94(2):496-501. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19589517

339. Tan S-L. [In vitro maturation: clinical and biological aspects]. J Gynecol Obstet Biol Reprod (Paris) [Internet]. 2003;32(3 Pt 2):S52-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12773921

340. Fadini R, Dal Canto MB, Mignini Renzini M, Brambillasca F, Comi R, Fumagalli D, et al. Effect of different gonadotrophin priming on IVM of oocytes from women with normal ovaries: a prospective randomized study. Reprod Biomed Online [Internet]. 2009;19(3):343-51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19778479

341. Chian RC, Buckett WM, Tulandi T, Tan SL. Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome. Hum Reprod [Internet]. 2000;15(1):165-70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10611207

342. Son W-Y, Chung J-T, Herrero B, Dean N, Demirtas E, Holzer H, et al. Selection of the optimal day for oocyte retrieval based on the diameter of the dominant follicle in hCGprimed in vitro maturation cycles. Hum Reprod [Internet]. 2008;23(12):2680-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18775885

343. Elizur SE, Son W-Y, Yap R, Gidoni Y, Levin D, Demirtas E, et al. Comparison of low-dose human menopausal gonadotropin and micronized 17beta-estradiol supplementation in in vitro maturation cycles with thin endometrial lining. Fertil Steril [Internet]. 2009;92(3):907-12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18976750

344. Buckett WM, Chian R-C, Holzer H, Dean N, Usher R, Tan SL. Obstetric outcomes and congenital abnormalities after in vitro maturation, in vitro fertilization, and intracytoplasmic sperm injection. Obstet Gynecol [Internet]. 2007;110(4):885-91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17906024

345. Fadini R, Mignini Renzini M, Guarnieri T, Dal Canto M, De Ponti E, Sutcliffe A, et al. Comparison of the obstetric and perinatal outcomes of children conceived from in vitro or in vivo matured oocytes in in vitro maturation treatments with births from conventional ICSI cycles. Hum Reprod. 2012;27(12):3601-8.

346. Cakmak H, Rosen MP. Ovarian stimulation in cancer patients. Fertil Steril. 2013 May;99(6):1476-84.

347. Coyne K, Purdy M, # K, Yaklic JL, Lindheim SR, Appiah LA. Challenges and Considerations in Optimizing Ovarian Stimulation Protocols in Oncofertility Patients. Front Public Heal [Internet]. 2014;2. Available from: http://journal.frontiersin.org/article/10.3389/fpubh.2014.00246/abstract

348. Reddy J, Turan V, Bedoschi G, Moy F, Oktay K. Triggering final oocyte maturation with gonadotropin-releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (hCG) in breast cancer patients undergoing fertility preservation: an extended experience. J Assist Reprod Genet [Internet]. 2014;31(7):927-32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24854484

349. Simon A, Laufer N. Repeated implantation failure: clinical approach. Fertil Steril [Internet]. 2012;97(5):1039-43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22464086

350. Polanski LT, Baumgarten MN, Quenby S, Brosens J, Campbell BK, Raine-Fenning NJ. What exactly do we mean by "recurrent implantation failure"? A systematic review and opinion. Reprod Biomed Online [Internet]. 2014;28(4):409-23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24581986

351. Coughlan C, Ledger W, Wang Q, Liu F, Demirol A, Gurgan T, et al. Recurrent implantation failure: definition and management. Reprod Biomed Online [Internet]. 2014;28(1):14-38. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24269084

352. Корсак В.С., Смирнова А.А., Шурыгина О.В. Регистр центров ВРТ в России. Отчет за 2013 г. Проблемы репродукции. 2015;21(6):16-32.

353. Корсак В.С., Смирнова А.А., Шурыгина О.В. Регистр центров ВРТ в России. Отчет за 2014 г. Проблемы репродукции. 2016;22(5):8-21.

354. European IVF-Monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE), Calhaz-Jorge C, de Geyter C, Kupka MS, de Mouzon J, Erb K, et al. Assisted reproductive technology in Europe, 2012: results generated from European registers by ESHRE. Hum Reprod. 2016;31(8):1638-52.

355. Bradshaw KD, Guzick DS, Grun B, Johnson N, Ackerman G. Cumulative pregnancy rates for donor insemination according to ovulatory function and tubal status. Fertil Steril [Internet]. 1987;48(6):1051-4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3678505

356. Hammond MG, Jordan S, Sloan CS. Factors affecting pregnancy rates in a donor insemination program using frozen semen. Am J Obstet Gynecol [Internet]. 1986;155(3):480-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3752170

357. Chauhan M, Barratt CL, Cooke SM, Cooke ID. Differences in the fertility of donor insemination recipients-a study to provide prognostic guidelines as to its success and outcome. Fertil Steril [Internet]. 1989;51(5):815-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2707456

358. ESHRE Capri Workshop Group. Intrauterine insemination. Hum Reprod Update [Internet]. 15(3):265-77. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19240042

359. Cantineau AEP, Heineman MJ, Cohlen BJ. Single versus double intrauterine insemination in stimulated cycles for subfertile couples: a systematic review based on a Cochrane review. Hum Reprod [Internet]. 2003; 18(5):941-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12721166



360. Green KA, Zolton JR, Schermerhorn SM V, Lewis TD, Healy MW, Terry N, et al. Progesterone luteal support after ovulation induction and intrauterine insemination: an updated systematic review and meta-analysis. Fertil Steril [Internet]. 2017;107(4):924-933.e5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28238492.
Согласовано


Главный внештатный специалист
Минздрава России по акушерству
и гинекологии
академик РАН

Л.В. Адамян


28 декабря 2018 г.


Поделитесь с Вашими друзьями:
1   ...   151   152   153   154   155   156   157   158   159


База данных защищена авторским правом ©zodorov.ru 2017
обратиться к администрации

    Главная страница